chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 63.0
Sex: M
Vaccine: COVID19
Symptoms: Incorrect dose administered, Wrong technique in device usage process
Clinical narrative: Pharmacist pushed in the plunger the vaccine sprayed on left arm, neck, cheek; Gave a second shot; A spontaneous report, was received from a consumer (patient), a 63-years old male patient, unknown race and ethnicity, who was administered Moderna's COVID-19 vaccine (mRNA-1273), and experienced pharmacist pushed in the plunger the vaccine sprayed on left arm, neck, cheek (wrong technique in device usage process) and gave a second shot (incorrect dose administered ).  The patient's medical history was not provided. Concomitant medications were not reported.  On 01 Mar 2021, prior to the onset of the symptoms, the patient received their second planned doses of mRNA-1273 (Batch number: 011A21A), intramuscularly for the prophylaxis of COVID-19 infection.  On 01 Mar 2021, the needle was bent or gone in incorrectly because when the pharmacist pushed in the plunger the vaccine sprayed on left cheek, neck and ran down arm. The patient doesn't think that the vaccine went into arm, so the pharmacist gave a second shot. The patient reported that he washed off the vaccine that got sprayed on him with dawn dish detergent. Treatment details were not provided.  Action taken with second dose of mRNA-1273 in response to the events was not applicable.  The outcome of the events, pharmacist pushed in the plunger the vaccine sprayed on left arm, neck, cheek and gave a second shot were considered as recovered on 01 Mar 2021.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache
Clinical narrative: Fatigue; Headache; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (Fatigue) and HEADACHE (Headache) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012A20A) for COVID-19 vaccination.     No Medical History information was reported.    On 25-Feb-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Feb-2021, the patient experienced FATIGUE (Fatigue) and HEADACHE (Headache). At the time of the report, FATIGUE (Fatigue) and HEADACHE (Headache) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Patient did not took any treatment. No concomitant medications were reported.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Breast pain, Chest pain, Chills, Cough, Diarrhoea
Clinical narrative: chest wall was hurting; Left breast was hot burning/ Left breast was hurting; chest wall was hot burning; sinus infection; Intense itching from top of my head to bottom of feet; Left breast was red/ Left breast was red; cough; Rash in the mid section; e\Extreme chills; Fever; extreme chills, fever, diarrhea for 10 days; This spontaneous case was reported by a consumer and describes the occurrence of MUSCULOSKELETAL CHEST PAIN (chest wall was hurting), BREAST PAIN (Left breast was hot burning/ Left breast was hurting), CHEST PAIN (chest wall was hot burning), SINUSITIS (sinus infection) and DIARRHOEA (extreme chills, fever, diarrhea for 10 days) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Chemotherapy. Concurrent medical conditions included Breast cancer stage IV since 2001 and Neuropathy. Concomitant products included VITAMIN C [ASCORBIC ACID] for an unknown indication.    On 20-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 20-Jan-2021, the patient experienced DIARRHOEA (extreme chills, fever, diarrhea for 10 days). On an unknown date, the patient experienced MUSCULOSKELETAL CHEST PAIN (chest wall was hurting), BREAST PAIN (Left breast was hot burning/ Left breast was hurting), CHEST PAIN (chest wall was hot burning), SINUSITIS (sinus infection), PRURITUS (Intense itching from top of my head to bottom of feet), ERYTHEMA (Left breast was red/ Left breast was red), COUGH (cough), RASH (Rash in the mid section), CHILLS (e\Extreme chills) and PYREXIA (Fever). At the time of the report, MUSCULOSKELETAL CHEST PAIN (chest wall was hurting), BREAST PAIN (Left breast was hot burning/ Left breast was hurting), CHEST PAIN (chest wall was hot burning), SINUSITIS (sinus infection), DIARRHOEA (extreme chills, fever, diarrhea for 10 days), PRURITUS (Intense itching from top of my head to bottom of feet), ERYTHEMA (Left breast was red/ Left breast was red), COUGH (cough), RASH (Rash in the mid section), CHILLS (e\Extreme chills) and PYREXIA (Fever) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment include Antibiotics and Sleepy ill herbal supplement.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Musculoskeletal chest pain, Pruritus, Pyrexia, Rash
Clinical narrative: chest wall was hurting; Left breast was hot burning/ Left breast was hurting; chest wall was hot burning; sinus infection; Intense itching from top of my head to bottom of feet; Left breast was red/ Left breast was red; cough; Rash in the mid section; e\Extreme chills; Fever; extreme chills, fever, diarrhea for 10 days; This spontaneous case was reported by a consumer and describes the occurrence of MUSCULOSKELETAL CHEST PAIN (chest wall was hurting), BREAST PAIN (Left breast was hot burning/ Left breast was hurting), CHEST PAIN (chest wall was hot burning), SINUSITIS (sinus infection) and DIARRHOEA (extreme chills, fever, diarrhea for 10 days) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Chemotherapy. Concurrent medical conditions included Breast cancer stage IV since 2001 and Neuropathy. Concomitant products included VITAMIN C [ASCORBIC ACID] for an unknown indication.    On 20-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 20-Jan-2021, the patient experienced DIARRHOEA (extreme chills, fever, diarrhea for 10 days). On an unknown date, the patient experienced MUSCULOSKELETAL CHEST PAIN (chest wall was hurting), BREAST PAIN (Left breast was hot burning/ Left breast was hurting), CHEST PAIN (chest wall was hot burning), SINUSITIS (sinus infection), PRURITUS (Intense itching from top of my head to bottom of feet), ERYTHEMA (Left breast was red/ Left breast was red), COUGH (cough), RASH (Rash in the mid section), CHILLS (e\Extreme chills) and PYREXIA (Fever). At the time of the report, MUSCULOSKELETAL CHEST PAIN (chest wall was hurting), BREAST PAIN (Left breast was hot burning/ Left breast was hurting), CHEST PAIN (chest wall was hot burning), SINUSITIS (sinus infection), DIARRHOEA (extreme chills, fever, diarrhea for 10 days), PRURITUS (Intense itching from top of my head to bottom of feet), ERYTHEMA (Left breast was red/ Left breast was red), COUGH (cough), RASH (Rash in the mid section), CHILLS (e\Extreme chills) and PYREXIA (Fever) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment include Antibiotics and Sleepy ill herbal supplement.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Sinusitis
Clinical narrative: chest wall was hurting; Left breast was hot burning/ Left breast was hurting; chest wall was hot burning; sinus infection; Intense itching from top of my head to bottom of feet; Left breast was red/ Left breast was red; cough; Rash in the mid section; e\Extreme chills; Fever; extreme chills, fever, diarrhea for 10 days; This spontaneous case was reported by a consumer and describes the occurrence of MUSCULOSKELETAL CHEST PAIN (chest wall was hurting), BREAST PAIN (Left breast was hot burning/ Left breast was hurting), CHEST PAIN (chest wall was hot burning), SINUSITIS (sinus infection) and DIARRHOEA (extreme chills, fever, diarrhea for 10 days) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Chemotherapy. Concurrent medical conditions included Breast cancer stage IV since 2001 and Neuropathy. Concomitant products included VITAMIN C [ASCORBIC ACID] for an unknown indication.    On 20-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 20-Jan-2021, the patient experienced DIARRHOEA (extreme chills, fever, diarrhea for 10 days). On an unknown date, the patient experienced MUSCULOSKELETAL CHEST PAIN (chest wall was hurting), BREAST PAIN (Left breast was hot burning/ Left breast was hurting), CHEST PAIN (chest wall was hot burning), SINUSITIS (sinus infection), PRURITUS (Intense itching from top of my head to bottom of feet), ERYTHEMA (Left breast was red/ Left breast was red), COUGH (cough), RASH (Rash in the mid section), CHILLS (e\Extreme chills) and PYREXIA (Fever). At the time of the report, MUSCULOSKELETAL CHEST PAIN (chest wall was hurting), BREAST PAIN (Left breast was hot burning/ Left breast was hurting), CHEST PAIN (chest wall was hot burning), SINUSITIS (sinus infection), DIARRHOEA (extreme chills, fever, diarrhea for 10 days), PRURITUS (Intense itching from top of my head to bottom of feet), ERYTHEMA (Left breast was red/ Left breast was red), COUGH (cough), RASH (Rash in the mid section), CHILLS (e\Extreme chills) and PYREXIA (Fever) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment include Antibiotics and Sleepy ill herbal supplement.
Age: 89.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Injection site bruising, Pallor
Clinical narrative: Bruise 5 inches in length; Pale; Red; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE BRUISING (Bruise 5 inches in length), PALLOR (Pale) and ERYTHEMA (Red) in an 89-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 023M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 20-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced INJECTION SITE BRUISING (Bruise 5 inches in length), PALLOR (Pale) and ERYTHEMA (Red). At the time of the report, INJECTION SITE BRUISING (Bruise 5 inches in length), PALLOR (Pale) and ERYTHEMA (Red) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported. No treatment related information has been reported.   Reporter did not allow further contact
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Back pain, Chills, Nasopharyngitis
Clinical narrative: Back pain; cold; Experienced chills; This spontaneous case was reported by a consumer and describes the occurrence of BACK PAIN (Back pain), NASOPHARYNGITIS (cold) and CHILLS (Experienced chills) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concomitant products included IRBESARTAN, ATORVASTATIN, FEBUXOSTAT, CALCITRIOL and LEVOTHYROXINE for an unknown indication.    On 03-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Feb-2021, the patient experienced BACK PAIN (Back pain), NASOPHARYNGITIS (cold) and CHILLS (Experienced chills). At the time of the report, BACK PAIN (Back pain), NASOPHARYNGITIS (cold) and CHILLS (Experienced chills) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment related information has been reported.
Age: 91.0
Sex: F
Vaccine: COVID19
Symptoms: Skin tightness
Clinical narrative: Tightness around the arm where she had the vaccination; This spontaneous case was reported by a consumer and describes the occurrence of SKIN TIGHTNESS (Tightness around the arm where she had the vaccination) in a 91-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 015M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 10-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Feb-2021, the patient experienced SKIN TIGHTNESS (Tightness around the arm where she had the vaccination). On 01-Mar-2021, SKIN TIGHTNESS (Tightness around the arm where she had the vaccination) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were reported. No treatment related information has been reported.   Most recent FOLLOW-UP information incorporated above includes: On 29-Apr-2021: TCR-event resolved
Sex: U
Vaccine: COVID19
Symptoms: Headache, Pyrexia
Clinical narrative: Headache; Fever; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (Headache) and PYREXIA (Fever) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced HEADACHE (Headache) and PYREXIA (Fever). At the time of the report, HEADACHE (Headache) and PYREXIA (Fever) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported. No treatment related information has been reported.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Eye inflammation, Fatigue, Headache, Herpes simplex
Clinical narrative: breakout of herpes simplex; Activation of sinus; Eye inflammation; 4 big cold sores on her lips; Fever; Chills; Fatigue; pounding headache/now dull and not pounding; This spontaneous case was reported by a consumer and describes the occurrence of HERPES SIMPLEX (breakout of herpes simplex), SINUS DISORDER (Activation of sinus), EYE INFLAMMATION (Eye inflammation), ORAL HERPES (4 big cold sores on her lips) and PYREXIA (Fever) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 042L20A and 002A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Dry eyes. Concomitant products included LISINOPRIL, Hydochlorothiazide, ROSUVASTATIN and ACETYLSALICYLIC ACID (BABY ASPIRIN) for an unknown indication.   On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 25-Feb-2021, the patient experienced HERPES SIMPLEX (breakout of herpes simplex), SINUS DISORDER (Activation of sinus), EYE INFLAMMATION (Eye inflammation), ORAL HERPES (4 big cold sores on her lips), PYREXIA (Fever), CHILLS (Chills), FATIGUE (Fatigue) and HEADACHE (pounding headache/now dull and not pounding). On 26-Feb-2021, CHILLS (Chills) and FATIGUE (Fatigue) had resolved. On 27-Feb-2021, HERPES SIMPLEX (breakout of herpes simplex), ORAL HERPES (4 big cold sores on her lips) and PYREXIA (Fever) had resolved. At the time of the report, SINUS DISORDER (Activation of sinus), EYE INFLAMMATION (Eye inflammation) and HEADACHE (pounding headache/now dull and not pounding) outcome was unknown.            No treatment related information has been reported.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Oral herpes, Pyrexia, Sinus disorder
Clinical narrative: breakout of herpes simplex; Activation of sinus; Eye inflammation; 4 big cold sores on her lips; Fever; Chills; Fatigue; pounding headache/now dull and not pounding; This spontaneous case was reported by a consumer and describes the occurrence of HERPES SIMPLEX (breakout of herpes simplex), SINUS DISORDER (Activation of sinus), EYE INFLAMMATION (Eye inflammation), ORAL HERPES (4 big cold sores on her lips) and PYREXIA (Fever) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 042L20A and 002A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Dry eyes. Concomitant products included LISINOPRIL, Hydochlorothiazide, ROSUVASTATIN and ACETYLSALICYLIC ACID (BABY ASPIRIN) for an unknown indication.   On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 25-Feb-2021, the patient experienced HERPES SIMPLEX (breakout of herpes simplex), SINUS DISORDER (Activation of sinus), EYE INFLAMMATION (Eye inflammation), ORAL HERPES (4 big cold sores on her lips), PYREXIA (Fever), CHILLS (Chills), FATIGUE (Fatigue) and HEADACHE (pounding headache/now dull and not pounding). On 26-Feb-2021, CHILLS (Chills) and FATIGUE (Fatigue) had resolved. On 27-Feb-2021, HERPES SIMPLEX (breakout of herpes simplex), ORAL HERPES (4 big cold sores on her lips) and PYREXIA (Fever) had resolved. At the time of the report, SINUS DISORDER (Activation of sinus), EYE INFLAMMATION (Eye inflammation) and HEADACHE (pounding headache/now dull and not pounding) outcome was unknown.            No treatment related information has been reported.
Sex: F
Vaccine: COVID19
Symptoms: Chills, Pain in extremity, Vaccination site swelling, Vaccination site warmth
Clinical narrative: arm still sore; arm little warm to the touch; chills; Swollen; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (arm still sore), VACCINATION SITE WARMTH (arm little warm to the touch), CHILLS (chills) and VACCINATION SITE SWELLING (Swollen) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002A21A) for COVID-19 vaccination.     The patient's past medical history included Blood pressure high, Thyroid disorder and Reflux gastritis.    On 26-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Feb-2021, the patient experienced PAIN IN EXTREMITY (arm still sore), VACCINATION SITE WARMTH (arm little warm to the touch), CHILLS (chills) and VACCINATION SITE SWELLING (Swollen). The patient was treated with PARACETAMOL (TYLENOL) for Adverse event, at an unspecified dose and frequency. At the time of the report, PAIN IN EXTREMITY (arm still sore), VACCINATION SITE WARMTH (arm little warm to the touch), CHILLS (chills) and VACCINATION SITE SWELLING (Swollen) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications included unspecified for high blood pressure, thyroid, reflux.
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: Sore arm at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Sore arm at the injection site) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028L20A) for COVID-19 vaccination.     Concurrent medical conditions included Asthma. Concomitant products included FLUTICASONE PROPIONATE, SALMETEROL XINAFOATE (ADVAIR), MONTELUKAST and METHYLPHENIDATE HYDROCHLORIDE (CONCERTA) for an unknown indication.    On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Jan-2021, the patient experienced VACCINATION SITE PAIN (Sore arm at the injection site). At the time of the report, VACCINATION SITE PAIN (Sore arm at the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment medication was not reported.   This case was linked to MOD-2021-030559 (Patient Link).
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Pruritus
Clinical narrative: red bumps are itchy; red bumps on her body; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (red bumps are itchy) and ERYTHEMA (red bumps on her body) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 015M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 05-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Feb-2021, the patient experienced PRURITUS (red bumps are itchy) and ERYTHEMA (red bumps on her body). The patient was treated with HYDROCORTISONE in February 2021 for Erythema and Itchy, at an unspecified dose and frequency. At the time of the report, PRURITUS (red bumps are itchy) and ERYTHEMA (red bumps on her body) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.   Most recent FOLLOW-UP information incorporated above includes: On 12-Jul-2021: Follow up received on 12-JUL-2021 contains no new information.
Age: 80.0
Sex: F
Vaccine: COVID19, UNK
Symptoms: Abdominal pain upper, Chills, Decreased appetite, Gastrointestinal pain, Pyrexia
Clinical narrative: Fever; Chills; Fever; Chills; Stomach cramps; Stabbing pain in gut; Loss of appetite; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of ABDOMINAL PAIN UPPER (Stomach cramps), GASTROINTESTINAL PAIN (Stabbing pain in gut), DECREASED APPETITE (Loss of appetite), the first episode of PYREXIA (Fever) and the first episode of CHILLS (Chills) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No other medical history reported.  Concurrent medical conditions included Food allergy (Unspecified), Drug allergy (Codeine) and Allergy to chemicals NOS (Highly allergic to chemicals - Felt tip pen).    On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Feb-2021, the patient experienced ABDOMINAL PAIN UPPER (Stomach cramps), GASTROINTESTINAL PAIN (Stabbing pain in gut), DECREASED APPETITE (Loss of appetite) and the first episode of CHILLS (Chills). On 13-Feb-2021, the patient experienced the first episode of PYREXIA (Fever). On 24-Feb-2021, the patient experienced the second episode of PYREXIA (Fever) and the second episode of CHILLS (Chills). On 17-Feb-2021, ABDOMINAL PAIN UPPER (Stomach cramps), GASTROINTESTINAL PAIN (Stabbing pain in gut) and DECREASED APPETITE (Loss of appetite) had resolved. At the time of the report, last episode of PYREXIA (Fever) and the last episode of CHILLS (Chills) had resolved.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was withdrawn on an unknown date.       Bismuth subsalicylate (PEPTOBISMOL) was noted as a concomitant medication but was also listed as a treatment medication.  The patient consulted her healthcare provider who recommended acetaminophen (TYLENOL) and water but no acetaminophen (TYLENOL) was consumed. The patient reported that her fever and chills recurred a week after her initial report, but have since resolved on an unknown date. The patient only received one dose of the vaccine because she was advised not to get the second dose. She was contemplating whether to get another vaccine for the second dose.   Reporter did not allow further contact   Most recent FOLLOW-UP information incorporated above includes: On 05-May-2021: New events of fever and chills added. Chemical allergy updated in medical history.
Age: 25.0
Sex: F
Vaccine: COVID19
Symptoms: Ear pain, Facial pain, Neck pain, Pain in jaw
Clinical narrative: Pain on half face, jaws, ears and neck like bells palsy; Pain on half face, jaws, ears and neck like bells palsy; Pain on half face, jaws, ears and neck like bells palsy; pain on half face, jaws, ears and neck like bells palsy; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN JAW (Pain on half face, jaws, ears and neck like bells palsy), EAR PAIN (Pain on half face, jaws, ears and neck like bells palsy), NECK PAIN (Pain on half face, jaws, ears and neck like bells palsy) and FACIAL PAIN (pain on half face, jaws, ears and neck like bells palsy) in a 25-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 05-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 07-Feb-2021, the patient experienced PAIN IN JAW (Pain on half face, jaws, ears and neck like bells palsy), EAR PAIN (Pain on half face, jaws, ears and neck like bells palsy), NECK PAIN (Pain on half face, jaws, ears and neck like bells palsy) and FACIAL PAIN (pain on half face, jaws, ears and neck like bells palsy). The patient was treated with IBUPROFEN for Adverse event, at an unspecified dose and frequency and PARACETAMOL (TYLENOL) for Adverse event, at an unspecified dose and frequency. At the time of the report, PAIN IN JAW (Pain on half face, jaws, ears and neck like bells palsy), EAR PAIN (Pain on half face, jaws, ears and neck like bells palsy), NECK PAIN (Pain on half face, jaws, ears and neck like bells palsy) and FACIAL PAIN (pain on half face, jaws, ears and neck like bells palsy) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medication was not reported.
Sex: F
Vaccine: COVID19
Symptoms: Chills, Feeling abnormal, Headache, Wheezing
Clinical narrative: unusual wheezing; felt lousy; headache; unusual chills; This spontaneous case was reported by a consumer and describes the occurrence of WHEEZING (unusual wheezing), FEELING ABNORMAL (felt lousy), HEADACHE (headache) and CHILLS (unusual chills) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 014M20A and 028L20A) for COVID-19 vaccination.     Concurrent medical conditions included Asthma and Wheezing. Concomitant products included FLUTICASONE PROPIONATE, SALMETEROL XINAFOATE (ADVAIR HFA), METHYLPHENIDATE HYDROCHLORIDE (CONCERTA) and MONTELUKAST for an unknown indication.   On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 25-Feb-2021, the patient experienced FEELING ABNORMAL (felt lousy), HEADACHE (headache) and CHILLS (unusual chills). On an unknown date, the patient experienced WHEEZING (unusual wheezing). The patient was treated with PREDNISONE for Wheezing, at an unspecified dose and frequency. At the time of the report, WHEEZING (unusual wheezing), FEELING ABNORMAL (felt lousy), HEADACHE (headache) and CHILLS (unusual chills) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Event treatment included nebulizer.   This case was linked to MOD-2021-030553 (Patient Link).
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Feeling abnormal, Pain in extremity
Clinical narrative: Her face was bright red on both sides and the neck; Looked like she was burned; Felt her leg got licked; Sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore arm), ERYTHEMA (Her face was bright red on both sides and the neck), ERYTHEMA (Looked like she was burned) and FEELING ABNORMAL (Felt her leg got licked) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 26-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Feb-2021, the patient experienced PAIN IN EXTREMITY (Sore arm). On 28-Feb-2021, the patient experienced ERYTHEMA (Her face was bright red on both sides and the neck), ERYTHEMA (Looked like she was burned) and FEELING ABNORMAL (Felt her leg got licked). At the time of the report, PAIN IN EXTREMITY (Sore arm), ERYTHEMA (Her face was bright red on both sides and the neck), ERYTHEMA (Looked like she was burned) and FEELING ABNORMAL (Felt her leg got licked) outcome was unknown.
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, Headache, Malaise, Pain, Pyrexia
Clinical narrative: Felt horrible; very weak; fever; headache; moaned from achiness; This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (Felt horrible), ASTHENIA (very weak), PYREXIA (fever), HEADACHE (headache) and PAIN (moaned from achiness) in a 76-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 030L20A and 077M70A) for COVID-19 vaccination.     Concomitant products included ATORVASTATIN CALCIUM, PRAMIPEXOLE and TRAZODONE for an unknown indication.   On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced MALAISE (Felt horrible), ASTHENIA (very weak), PYREXIA (fever), HEADACHE (headache) and PAIN (moaned from achiness). At the time of the report, MALAISE (Felt horrible), ASTHENIA (very weak), PYREXIA (fever), HEADACHE (headache) and PAIN (moaned from achiness) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       This case was linked to US-MODERNATX, INC.-MOD-2021-055528 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-055528:Second Dose
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Myalgia
Clinical narrative: weakness; muscle aches; This spontaneous case was reported by a consumer and describes the occurrence of ASTHENIA (weakness) and MYALGIA (muscle aches) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 024M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 18-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Feb-2021, the patient experienced ASTHENIA (weakness) and MYALGIA (muscle aches). On 27-Feb-2021, ASTHENIA (weakness) and MYALGIA (muscle aches) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medication was not reported.  Treatment medication was not reported.    This case was linked to MOD-2021-030607 (Patient Link).
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Pruritus, Rash
Clinical narrative: After 72 hours, Friday, started feeling a bit of itching all over the body, mostly during the night; Some rash on hands; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (After 72 hours, Friday, started feeling a bit of itching all over the body, mostly during the night) and RASH (Some rash on hands) in a 39-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 023M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 23-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PRURITUS (After 72 hours, Friday, started feeling a bit of itching all over the body, mostly during the night) and RASH (Some rash on hands). At the time of the report, PRURITUS (After 72 hours, Friday, started feeling a bit of itching all over the body, mostly during the night) and RASH (Some rash on hands) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication taken.   No treatment medication was provided.   This case was linked to MOD-2021-097637 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 29-Apr-2021: Additional information received was no new information for this case; adverse event reported for second dose.
Sex: F
Vaccine: COVID19
Symptoms: Paraesthesia, Paraesthesia oral, Tongue disorder
Clinical narrative: tongue still feels strange; tingling and numbness in cheeks, lips and tongue; tingling and numbness in cheeks, lips and tongue; This spontaneous case was reported by a nurse and describes the occurrence of PARAESTHESIA (tingling and numbness in cheeks, lips and tongue), PARAESTHESIA ORAL (tingling and numbness in cheeks, lips and tongue) and TONGUE DISORDER (tongue still feels strange) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Feb-2021, the patient experienced PARAESTHESIA (tingling and numbness in cheeks, lips and tongue) and PARAESTHESIA ORAL (tingling and numbness in cheeks, lips and tongue). On 27-Feb-2021, the patient experienced TONGUE DISORDER (tongue still feels strange). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) for Adverse event, at an unspecified dose and frequency. At the time of the report, PARAESTHESIA (tingling and numbness in cheeks, lips and tongue), PARAESTHESIA ORAL (tingling and numbness in cheeks, lips and tongue) and TONGUE DISORDER (tongue still feels strange) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medication was not reported.   Reporter did not allow further contact   Most recent FOLLOW-UP information incorporated above includes: On 01-Mar-2021: Additional information received including reporter email, adverse event terms, event treatment, event outcome.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Chills, Pyrexia, Vaccination site pain
Clinical narrative: Chills; Fever; Left Arm Hurts; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (Chills), PYREXIA (Fever) and VACCINATION SITE PAIN (Left Arm Hurts) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 79/11M20A) for COVID-19 vaccination.     No Medical History was provided by the reporter.   On 02-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form.   On 03-Feb-2021, the patient experienced CHILLS (Chills), PYREXIA (Fever) and VACCINATION SITE PAIN (Left Arm Hurts).   The patient was treated with PARACETAMOL (TYLENOL) on 10-Feb-2021 for Fever and Pain in arm, at an unspecified dose and frequency.   At the time of the report, CHILLS (Chills), PYREXIA (Fever) and VACCINATION SITE PAIN (Left Arm Hurts) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 03-Feb-2021, Body temperature: 101.6 (High) Patient has Fever of 101.6 F.   The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   Concomitant product use was not provided by the reporter.
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Petechiae, Platelet count
Clinical narrative: on her left forearm she had 5 new petechiae spots in a row; This spontaneous case was reported by a consumer and describes the occurrence of PETECHIAE (on her left forearm she had 5 new petechiae spots in a row) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031L20A) for COVID-19 vaccination.     Concurrent medical conditions included Petechiae. Concomitant products included LISINOPRIL for an unknown indication.    On 10-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PETECHIAE (on her left forearm she had 5 new petechiae spots in a row). At the time of the report, PETECHIAE (on her left forearm she had 5 new petechiae spots in a row) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In 2021, Platelet count: normal (normal) Normal.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment medication was not reported.   Most recent FOLLOW-UP information incorporated above includes: On 15-Jul-2021: Significant followup document was received on 15-JUL-2021 and it includes outcome of the event (on her left forearm she had 5 new petechiae spots in a row)
Age: 86.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Vaccination site induration, Vaccination site pruritus, Vaccination site swelling
Clinical narrative: Itching at the injection site; Hot to touch at injection site; Swelling and hardness at injection site; Swelling and hardness at injection site; Fatigue; Chills; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 02-Mar-2021 and was forwarded to Moderna on 03-Mar-2021.    This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (Hot to touch at injection site), VACCINATION SITE INDURATION (Swelling and hardness at injection site), VACCINATION SITE SWELLING (Swelling and hardness at injection site), FATIGUE (Fatigue) and CHILLS (Chills) in an 86-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029/20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In February 2021, the patient experienced VACCINATION SITE WARMTH (Hot to touch at injection site), VACCINATION SITE INDURATION (Swelling and hardness at injection site), VACCINATION SITE SWELLING (Swelling and hardness at injection site), FATIGUE (Fatigue) and CHILLS (Chills). On an unknown date, the patient experienced VACCINATION SITE PRURITUS (Itching at the injection site). At the time of the report, VACCINATION SITE WARMTH (Hot to touch at injection site), VACCINATION SITE INDURATION (Swelling and hardness at injection site), VACCINATION SITE SWELLING (Swelling and hardness at injection site), FATIGUE (Fatigue), CHILLS (Chills) and VACCINATION SITE PRURITUS (Itching at the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 86.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site warmth
Clinical narrative: Itching at the injection site; Hot to touch at injection site; Swelling and hardness at injection site; Swelling and hardness at injection site; Fatigue; Chills; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 02-Mar-2021 and was forwarded to Moderna on 03-Mar-2021.    This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (Hot to touch at injection site), VACCINATION SITE INDURATION (Swelling and hardness at injection site), VACCINATION SITE SWELLING (Swelling and hardness at injection site), FATIGUE (Fatigue) and CHILLS (Chills) in an 86-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029/20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In February 2021, the patient experienced VACCINATION SITE WARMTH (Hot to touch at injection site), VACCINATION SITE INDURATION (Swelling and hardness at injection site), VACCINATION SITE SWELLING (Swelling and hardness at injection site), FATIGUE (Fatigue) and CHILLS (Chills). On an unknown date, the patient experienced VACCINATION SITE PRURITUS (Itching at the injection site). At the time of the report, VACCINATION SITE WARMTH (Hot to touch at injection site), VACCINATION SITE INDURATION (Swelling and hardness at injection site), VACCINATION SITE SWELLING (Swelling and hardness at injection site), FATIGUE (Fatigue), CHILLS (Chills) and VACCINATION SITE PRURITUS (Itching at the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Vaccination site erythema, Vaccination site swelling
Clinical narrative: swelling; red ring around injection site; fatigue; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE SWELLING (swelling), VACCINATION SITE ERYTHEMA (red ring around injection site) and FATIGUE (fatigue) in a 55-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 023M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 22-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Feb-2021, the patient experienced VACCINATION SITE SWELLING (swelling), VACCINATION SITE ERYTHEMA (red ring around injection site) and FATIGUE (fatigue). At the time of the report, VACCINATION SITE SWELLING (swelling), VACCINATION SITE ERYTHEMA (red ring around injection site) and FATIGUE (fatigue) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication was not reported.  Treatment medication was not reported.
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Feeling hot
Clinical narrative: got real hot on the inside that lasted for 2 days; very weak; This spontaneous case was reported by a consumer and describes the occurrence of FEELING HOT (got real hot on the inside that lasted for 2 days) and ASTHENIA (very weak) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for an unknown indication.     Concurrent medical conditions included Diabetes.    On 23-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced FEELING HOT (got real hot on the inside that lasted for 2 days) and ASTHENIA (very weak). At the time of the report, FEELING HOT (got real hot on the inside that lasted for 2 days) had resolved and ASTHENIA (very weak) was resolving.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medications were not reported. Treatment information was not provided.
Age: 27.0
Sex: F
Vaccine: COVID19
Symptoms: Maternal exposure during pregnancy, Pregnancy test, Ultrasound foetal
Clinical narrative: Maternal exposure during pregnancy; This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of MATERNAL EXPOSURE DURING PREGNANCY (Maternal exposure during pregnancy) in a 27-year-old female patient (gravida 5, para 1) who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012A21A) for COVID-19 vaccination.     The patient's past medical history included Miscarriage (Miscarriage OCT 2019 first trimester Miscarriage FEB 2020 first trimester Miscarriage Jun 2020 first trimester) and Thyroid dysfunction in pregnancy in March 2020. Concurrent medical conditions included Seasonal allergy since August 2020. Concomitant products included FLUTICASONE PROPIONATE (FLONASE ALLERGY RELIEF) for Seasonal allergy, LEVOTHYROXINE for Thyroid dysfunction in pregnancy, PRENATAL + DHA.    On 01-Mar-2021 at 12:30 PM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. The patient's last menstrual period was on 28-Aug-2020 and the estimated date of delivery was 14-Jun-2021. On 01-Mar-2021, the patient experienced MATERNAL EXPOSURE DURING PREGNANCY (Maternal exposure during pregnancy). The patient received mRNA-1273 (Moderna COVID-19 Vaccine) beginning around the  twenty-sixth week of the pregnancy.  On 01-Mar-2021, MATERNAL EXPOSURE DURING PREGNANCY (Maternal exposure during pregnancy) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In September 2020, Pregnancy test: positive (Positive) Positive. On 29-Jan-2021, Ultrasound foetal: abnormal (abnormal) Marginal cord insertion.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment medication was not reported.  Previous pregnancies reported as live full-term birth on 20-Dec-2014 and other 3 were miscarriage in Oct-2019, Feb-2020 and Jun-2020 respectively. Estimated date of conception was reported in Sep-2020.
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Maternal exposure during pregnancy
Clinical narrative: Vaccine exposure during pregnancy; This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of MATERNAL EXPOSURE DURING PREGNANCY (Vaccine exposure during pregnancy) in a 32-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 01-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. The patient's last menstrual period was on 08-Aug-2020 and the estimated date of delivery was 08-May-2021. On 01-Mar-2021, the patient experienced MATERNAL EXPOSURE DURING PREGNANCY (Vaccine exposure during pregnancy). The patient received mRNA-1273 (Moderna COVID-19 Vaccine) beginning around the  twenty-ninth week of the pregnancy.  On 01-Mar-2021, MATERNAL EXPOSURE DURING PREGNANCY (Vaccine exposure during pregnancy) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medication was not reported.  Treatment medication was not reported.